Home Stock

Stock Research: Guardant Health

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Guardant Health

NSQ:GH US40131M1099
54
  • Value
    54
  • Growth
    99
  • Safety
    Safety
    1
  • Combined
    62
  • Sentiment
    47
  • 360° View
    360° View
    54
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Guardant Health, Inc. is a precision oncology company providing insights into disease drivers through advanced blood and tissue tests, real-world data, and AI analytics to improve cancer outcomes across all stages of care. Its main businesses involve screening for early cancer, monitoring for recurrence, and helping doctors select advanced cancer treatments, including Guardant360 LDT, Guardant360 CDx for NSCLC and breast cancer, Guardant360 Tissue, Guardant Reveal, and Guardant360 Response. The description does not specify different regions of operation. In the last fiscal year, the company had a market cap of $5995 million, profits of $449 million, revenue of $739 million, and 1999 employees.

more
Strongest Rank Safety
Weakest Rank Price vs. Book (P/B)
Country USA
Industry Health Care Services
Size Large
Website guardanthealth.com
Index
NASDAQ
D.J. US Health Care
Guardant Health stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 19-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
54 65 6 10
Growth
99 93 82 14
Safety
Safety
1 7 14 26
Sentiment
47 70 37 20
360° View
360° View
54 79 12 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
83 84 72 81
Opinions Change
60 68 47 43
Pro Holdings
n/a 57 10 12
Market Pulse
24 27 29 15
Sentiment
47 70 37 20
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
54 65 6 10
Growth
99 93 82 14
Safety Safety
1 7 14 26
Combined
62 64 10 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
8 26 7 3
Price vs. Earnings (P/E)
3 3 3 4
Price vs. Book (P/B)
100 100 3 11
Dividend Yield
1 1 1 1
Value
54 65 6 10
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
85 76 89 72
Profit Growth
55 60 73 19
Capital Growth
93 81 97 18
Stock Returns
95 95 32 22
Growth
99 93 82 14
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
4 5 5 31
Refinancing
27 51 80 76
Liquidity
1 11 9 9
Safety Safety
1 7 14 26

Similar Stocks

Discover high‑ranked alternatives to Guardant Health and broaden your portfolio horizons.

Sandisk

NSQ:SNDK
Country: USA
Industry: Technology Hardware & Peripherals
Size: X-Large
Full Stock Analysis

Aramark

NYQ:ARMK
Country: USA
Industry: Restaurants
Size: X-Large
Full Stock Analysis

Micron

NSQ:MU
Country: USA
Industry: Semiconductors
Size: XX-Large
Full Stock Analysis

ResMed

NYQ:RMD
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This is a high-quality, high-growth stock with positive sentiment. However, the financing is on the riskier side. It is best for a growth-focused investor willing to accept higher financial risk for potentially higher shareholder returns.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews